Per the ADA consensus report, several observational studies show that patients with diabetes, when treated with metformin compared to other agents such as sulfonylureas and insulin, have a lower risk of cancer or cancer mortality.?? These observational studies, however, are likely confounded; the patients taking metformin were generally healthier and had a shorter history of diabetes than those on